Skip to main content
Fig. 10 | Cancer Cell International

Fig. 10

From: Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways

Fig. 10

Effects of DA (1 µM) and BMS-202 (1 µM) inhibitors on angiogenesis using the CAM of the chicken embryo for 48 h. DA and BMS-202 in combination inhibit angiogenesis of the CAM compared with those exposed to DA and BMS-202, individually as well as with DMSO (control). CAM was treated for 48 h as shown in the materials and methods section (a). Images were quantified using AngioTool software to measure changes in blood vessel parameters (b)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us